YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
Google AI co-scientist is a multi-agent research system that helps scientists develop, critique and rank hypotheses and experimental proposals. Isomorphic Labs is an AI drug-design company developing therapeutics through internal programs and pharmaceutical partnerships. Ratings are subjective editorial opinions for each product’s stated purpose, not measured benchmarks.
Isomorphic Labs is an AI drug-design company developing therapeutics through internal programs and pharmaceutical partnerships. Its predictive and generative models support molecular design and in-silico experiments for small molecules and biologics. Scientists must select, test and validate candidates; a designed molecule is not an approved medicine.
Google AI co-scientist is a multi-agent research system that helps scientists develop, critique and rank hypotheses and experimental proposals. Specialized generation, reflection, ranking, evolution and review agents iterate on a scientist’s goal. The output supports research planning; experimental validation and scientific conclusions remain human responsibilities.
These scores express our judgement of the cited product facts. They are not measured performance benchmarks. Each product is assessed for its stated purpose; a higher score does not make different workflows interchangeable.
Evidence gaps lower confidence and affect the relevant judgement. Unknown pricing does not mean free access. Research prototypes and retired products retain their historical scope, with adoption ratings reflecting current access.
Ratings assessed: 2026-11-07. Source verification dates may differ.
Documented capability: How useful and complete is the documented workflow for the product's stated purpose?
Ease of adoption: Can the intended user obtain and set up a usable product today?
Value and cost clarity: How attractive and understandable is the cost model for the documented use?
Integration options: How useful and extensible are the verified user-facing connections for the intended workflow?
Google AI Co-Scientist: 6/10
Evidence confidence: high
Specialized generation, reflection, ranking, evolution and review agents iterate on a scientist’s goal. The output supports research planning; experimental validation and scientific conclusions remain human responsibilities.
Isomorphic Labs: 7/10
Evidence confidence: high
Its predictive and generative models support molecular design and in-silico experiments for small molecules and biologics. Scientists must select, test and validate candidates; a designed molecule is not an approved medicine.
The scores judge completeness for each stated purpose; different workflows are not interchangeable.
Google AI Co-Scientist: 3/10
Evidence confidence: high
Gemini Enterprise documents restricted preview access through a Google account team. Google Labs also offers an expression-of-interest route for Hypothesis Generation built with co-scientist; neither is ordinary unrestricted consumer access.
Isomorphic Labs: 3/10
Evidence confidence: high
This is a specialist research organization and partnership route, not a self-service research assistant that an individual can subscribe to.
Access, setup and human responsibilities matter alongside features.
Google AI Co-Scientist: 3/10
Evidence confidence: high
Preview access and commercial terms need confirmation with Google. A consumer Gemini subscription price is not a verified price for co-scientist.
Isomorphic Labs: 3/10
Evidence confidence: high
Commercial collaborations have negotiated terms. There is no public per-seat software offer to use as a purchasing comparison.
Compare the full cost of your intended workflow, including external services and implementation.
Google AI Co-Scientist: 4/10
Evidence confidence: high
The documented access path is Gemini Enterprise, with optional Cloud Logging for runs. This does not establish general-purpose Teams, GitHub or email connectors for the research system.
Isomorphic Labs: 3/10
Evidence confidence: high
Pharmaceutical partnerships are research collaborations, not software connectors. A public general-purpose drug-design API is not part of the published offer.
Choose the connections your workflow needs, rather than counting partner logos.
Consider co-scientist for hypothesis development if your research organization can obtain preview access and validate the resulting proposals.
Consider Isomorphic Labs in the context of pharmaceutical research partnerships, not as an immediately available desktop or web agent.
YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
Give businesses AI teams that own ongoing roles. Set your pricing, delegate routine coordination and build a recurring service.